Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. Other stock markets 00:42:12 2026-07-23 EDT			5-day change	1st Jan Change
2,539.20 ^INR	-0.47%		+1.30%	+2.76%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	432,172	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	11.72%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	432,172	432,172
Change	-	-18.99%	58.51%	48.08%	-20.64%	11.72%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	37.6x	33.4x
PBR	10.6x	12.9x	18.5x	25x	17.1x	16.5x	13x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.4x	2.6x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	10.3x	9.3x
EV / Revenue	0x	0x	0x	0x	0x	10.3x	9.3x
EV / EBITDA	0x	0x	0x	0x	0x	29.6x	26.2x
EV / EBIT	0x	0x	0x	0x	0x	31.4x	27.5x
EV / FCF	0x	0x	0x	0x	0x	37.3x	33.6x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.68%	2.97%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.16%	1.16%
EPS ²	100	36.05	34.83	54.76	61.15	67.9	76.48
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.4%	38.6%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,989	46,489
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,603	16,493
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,417	12,543
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,551.10	2,551.10
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	36.9x	-	-	1.18%	4.48B
ELI LILLY AND COMPANY	34.93x	12.49x	26.13x	0.58%	1,037B
JOHNSON & JOHNSON	26.93x	6.14x	16.82x	2.14%	615B
ABBVIE INC.	33.36x	7.57x	15.52x	2.68%	448B
ROCHE HOLDING AG	17.83x	4.42x	10.88x	3%	326B
NOVARTIS AG	21.97x	5.47x	13.3x	2.81%	293B
ASTRAZENECA PLC	20.86x	4.4x	12.18x	2%	264B
NOVO NORDISK A/S	14.29x	5.31x	10.95x	3.5%	216B
AMGEN INC.	24.02x	6.34x	11.18x	2.75%	198B
GILEAD SCIENCES, INC.	-46.93x	5.62x	31.07x	2.53%	162B
Average	18.42x	6.42x	16.45x	2.32%	356.19B
Weighted average by Cap.	24.11x	7.77x	18.17x	2.01%